Phase 3 Study to Compare the Efficacy and Safety of Gemigliptin and Vildagliptin as Add-on Therapy to Metformin in People With Type 2 Diabetes Inadequately Controlled With Metformin
Clinical trial NCT02343926 · COMPLETED
Trial details
- NCT number
- NCT02343926
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2016-04-01
- Enrollment
- 443
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.